📰 Luye Pharma News
Luye Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Luye Pharma. Real-time updates on events, politics, business and more.
May 2, 2024
Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The
March 24, 2024
These therapies can improve treatment adherence for patients, especially for those with a history of poor or uncertain adherence.
March 11, 2024
Market OverviewThe Buprenorphine Transdermal Patches Market has gained significant traction in recent years as a viable solution for managing chronic pain and opioid use disorder. Buprenorphine, a partial opioid agonist, is an effective medication for treating opioid addiction and chronic pain conditions. Transderma...
December 15, 2023
Microtubule Inhibitor Drugs Market Analysis and Future Prospects for 2030
November 10, 2023
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 9, 2023--
August 2, 2023
BASEL, Switzerland, BEIJING, & CAMBRIDGE, Mass., August 02, 2023--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today reported financial results from the second quarter of 2023 and business highlights.
July 6, 2023
/PRNewswire/ -- DelveInsights Esophageal Cancer Market Insights report includes a comprehensive understanding of current treatment practices, esophageal...
April 5, 2023
/PRNewswire/ -- DelveInsights Schizophrenia Pipeline Insight – 2023 report provides comprehensive global coverage of available, marketed, and pipeline...
April 5, 2023
Luye Pharma Group has signed a marketing and distribution agreement with Duopharma Marketing for a cholesterol management product in Malaysia.
April 5, 2023
Increase in Research and Development activities for advancements in anti-psychotic drugs, product launches, and approvals has increased the Schizophrenia market. An increase in the development